Veralliance Properties
Eli Lilly Completes $90M Biotech Expansion in San Diego
The expansion more than doubles the firm’s existing Biotechnology Center, as part of the company’s $850 million U.S. capital investment for 2017.
The expansion more than doubles the firm’s existing Biotechnology Center, as part of the company’s $850 million U.S. capital investment for 2017.